Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Avacta Group's share price for the quarter that ended in Dec. 2023 was £1.165. Avacta Group's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 288.29 Mil. Therefore, Avacta Group's market cap for the quarter that ended in Dec. 2023 was £335.85 Mil.
Avacta Group's quarterly market cap
declined
from Dec. 2022 (£305.99 Mil) to Jun. 2023 (£300.27 Mil) but then
increased
from Jun. 2023 (£300.27 Mil) to Dec. 2023 (£335.85 Mil).
Avacta Group's annual market cap
declined
from Dec. 2021 (£320.99 Mil) to Dec. 2022 (£305.99 Mil) but then
increased
from Dec. 2022 (£305.99 Mil) to Dec. 2023 (£335.85 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Avacta Group's Enterprise Value for Today is £165.76 Mil.
Avacta Group Market Cap Historical Data
The historical data trend for Avacta Group's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Avacta Group's Market Cap
For the Biotechnology subindustry, Avacta Group's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avacta Group's Market Cap Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Avacta Group's Market Cap distribution charts can be found below:
* The bar in red indicates where Avacta Group's Market Cap falls into.
Avacta Group Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Avacta Group's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avacta Group (LSE:AVCT) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Avacta Group Market Cap Related Terms
Thank you for viewing the detailed overview of Avacta Group's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Avacta Group PLC is a United Kingdom-based biotechnology company. The company offers its products through three segments that are Diagnostics, Therapeutics, and Animal Health. The company is developing novel cancer immunotherapies combining its two proprietary platforms Affimer biotherapeutics and precision tumor-targeted chemotherapy. The company operates in the United Kingdom, France, South Korea, Rest of Europe, Asia, and North America.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LSE:AVCT has been successfully added to your 